| Latest | F'cast | |
|---|---|---|
| Div Yield | 1.0% | 0.0% |
| Div Cover | 4.9 | 5.5 |
| Op Mrgn | 5.1% | 7.3% |
| ROCE | 10.3% |
| Latest | F'cast | |
|---|---|---|
| P/E | 20.3 | 17.4 |
| PEG | 0.7 | 1.0 |
| Pr/Revenue | 1.0 | 0.9 |
| Pr/Book | 1.4 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 14.5% | 14.5% |
| PBT | 18.8% | 91.0% |
| EPS | 28.2% | 16.6% |
| DPS | 4.3% | 4.1% |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-May-21 | 98.52 | 5.45 | 22.80p | 14.7 | 0.1 | +182% | 4.00p | 1.2% |
| 31-May-22 | 99.07 | 6.97 | 21.60p | 20.8 | n/a | -5% | 4.20p | 0.9% |
| 31-May-23 | 116.44 | 7.48 | 23.40p | 17.5 | 2.2 | +8% | 4.50p | 1.1% |
| 31-May-24 | 136.62 | 4.82 | 18.80p | 20.5 | n/a | -20% | 4.70p | 1.2% |
| 31-May-25 | 156.41 | 6.86 | 24.10p | 17.0 | 0.6 | +28% | 4.90p | 1.2% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-May-26 | 179.10 | 13.10 | 28.11p | 17.4 | 1.0 | +17% | 5.10p | 0.0% |
| 31-May-27 | 193.40 | 16.50 | 37.10p | 13.2 | 0.4 | +32% | 5.40p | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
| Exercise of Options & PDMR Dealings | 14-Nov-2025 | 08:38 | RNS |
| Adaptix receives FDA 510(K) clearance | 10-Nov-2025 | 07:00 | RNS |
| Exercise of Options & Total Voting Rights | 01-Oct-2025 | 16:52 | RNS |
| Traded | Action | Notifier | Price | Amount | Value |
|---|---|---|---|---|---|
| 13-Nov-25 | Exercise of option | Stephen King | 0.000p | 187,422 | £0.00 |
| 13-Nov-25 | Exercise of option | Stephen King | 520.00p | 68,254 | £354,920.79 |
| Currency | UK Pounds |
| Share Price | 490.00p |
| Change Today | -5.00p |
| % Change | -1.01 % |
| 52 Week High | 520.00 |
| 52 Week Low | 310.00 |
| Volume | 76,438 |
| Shares Issued | 33.13m |
| Market Cap | £162.34m |
| RiskGrade | 130 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 0 |
| Buy | 1 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 1 |

| Latest | Previous | |
|---|---|---|
| Final | Interim | |
| Ex-Div | 06-Nov-25 | 29-May-25 |
| Paid | 19-Dec-25 | 27-Jun-25 |
| Amount | 3.00p | 1.90p |
| Time | Volume / Share Price |
| 17:08 | 711 @ 490.00p |
| 16:26 | 1,215 @ 494.40p |
| 16:02 | 1,000 @ 494.40p |
| 15:52 | 460 @ 486.55p |
| 15:48 | 758 @ 480.00p |
| Finance Director | Stephen King |
| Chair | Roger Steven McDowell |
| CEO | Stephen McQuillan |
You are here: research